Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (1) , 49-57
- https://doi.org/10.1016/j.bbmt.2003.08.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantationBone Marrow Transplantation, 2003
- Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityBlood, 2003
- High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantationBone Marrow Transplantation, 2002
- Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitutionThe Lancet, 2000
- CD34+ cell dose predicts relapse and survival after T‐cell‐depleted HLA‐identical haematopoietic stem cell transplantation (HSCT) for haematological malignanciesBritish Journal of Haematology, 2000
- T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopeniaBone Marrow Transplantation, 1998
- CYTOMEGALOVIRUS PNEUMONIA AFTER BONE MARROW TRANSPLANTATIONTransplantation, 1993
- Immunosuppressive Effects of Ganciclovir on in Vitro Lymphocyte ResponsesThe Journal of Infectious Diseases, 1987
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958